Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Related Articles by Review for PubMed (Select 23314404)

1.

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship.

Vagelatos NT, Eslick GD.

Epidemiol Rev. 2013;35:152-60. doi: 10.1093/epirev/mxs012. Epub 2013 Jan 11.

PMID:
23314404
2.

Alzheimer disease and cerebrovascular pathology: an update.

Jellinger KA.

J Neural Transm. 2002 May;109(5-6):813-36. Review.

PMID:
12111471
3.

Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies.

Almeida OP, Hulse GK, Lawrence D, Flicker L.

Addiction. 2002 Jan;97(1):15-28. Review.

PMID:
11895267
4.

Nimodipine for primary degenerative, mixed and vascular dementia.

López-Arrieta JM, Birks J.

Cochrane Database Syst Rev. 2002;(3):CD000147. Review.

PMID:
12137606
5.

Diabetes, Alzheimer's disease and apolipoprotein genotype.

Messier C.

Exp Gerontol. 2003 Sep;38(9):941-6. Review.

PMID:
12954480
6.

An update on type 2 diabetes, vascular dementia and Alzheimer's disease.

Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ.

Exp Gerontol. 2012 Nov;47(11):858-64. doi: 10.1016/j.exger.2012.07.014. Epub 2012 Aug 3. Review.

PMID:
22884853
7.

The role of cerebral ischemia in Alzheimer's disease.

Kalaria RN.

Neurobiol Aging. 2000 Mar-Apr;21(2):321-30. Review.

PMID:
10867217
8.

Update on hypertension and Alzheimer's disease.

Skoog I, Gustafson D.

Neurol Res. 2006 Sep;28(6):605-11. Review.

PMID:
16945211
9.

Diabetes mellitus and dementia.

Pasquier F, Boulogne A, Leys D, Fontaine P.

Diabetes Metab. 2006 Nov;32(5 Pt 1):403-14. Review.

10.

Vascular risk factors and Alzheimer's disease.

Cechetto DF, Hachinski V, Whitehead SN.

Expert Rev Neurother. 2008 May;8(5):743-50. doi: 10.1586/14737175.8.5.743. Review.

PMID:
18457531
11.

The pathology of "vascular dementia": a critical update.

Jellinger KA.

J Alzheimers Dis. 2008 May;14(1):107-23. Review.

PMID:
18525132
12.

Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis.

Seitz DP, Shah PS, Herrmann N, Beyene J, Siddiqui N.

BMC Geriatr. 2011 Dec 14;11:83. doi: 10.1186/1471-2318-11-83. Review.

13.

Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Carlsson CM.

J Alzheimers Dis. 2010;20(3):711-22. doi: 10.3233/JAD-2010-100012. Review.

14.

Hypertension, hypertension-clustering factors and Alzheimer's disease.

Skoog I, Gustafson D.

Neurol Res. 2003 Sep;25(6):675-80. Review.

PMID:
14503023
15.

Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis.

Bao W, Rong Y, Rong S, Liu L.

BMC Med. 2012 Oct 10;10:119. doi: 10.1186/1741-7015-10-119. Review.

16.

Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms.

Mushtaq G, Khan JA, Kumosani TA, Kamal MA.

Saudi J Biol Sci. 2015 Jan;22(1):4-13. doi: 10.1016/j.sjbs.2014.05.003. Epub 2014 May 23. Review.

17.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
18.

Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence.

Kunutsor SK, Apekey TA, Walley J, Kain K.

Diabetes Metab Res Rev. 2013 May;29(4):308-18. doi: 10.1002/dmrr.2394. Review.

PMID:
23381919
19.

Interventions for heart disease and their effects on Alzheimer's disease.

Wolozin B, Bednar MM.

Neurol Res. 2006 Sep;28(6):630-6. Review.

20.

Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Lopez OL, Becker JT, Kuller LH.

J Alzheimers Dis. 2013;33 Suppl 1:S427-38. doi: 10.3233/JAD-2012-129015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk